Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 39
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Waltz, James A. 2016. The neural underpinnings of cognitive flexibility and their disruption in psychotic illness. Neuroscience,

    Thakkar, Katharine N. Schall, Jeffrey D. Logan, Gordon D. and Park, Sohee 2015. Cognitive control of gaze in bipolar disorder and schizophrenia. Psychiatry Research, Vol. 225, Issue. 3, p. 254.

    Thakkar, Katharine N. Schall, Jeffrey D. Logan, Gordon D. and Park, Sohee 2015. Response inhibition and response monitoring in a saccadic double-step task in schizophrenia. Brain and Cognition, Vol. 95, p. 90.

    Ethridge, Lauren E. Soilleux, Melanie Nakonezny, Paul A. Reilly, James L. Kristian Hill, S. Keefe, Richard S.E. Gershon, Elliot S. Pearlson, Godfrey D. Tamminga, Carol A. Keshavan, Matcheri S. and Sweeney, John A. 2014. Behavioral response inhibition in psychotic disorders: Diagnostic specificity, familiality and relation to generalized cognitive deficit. Schizophrenia Research, Vol. 159, Issue. 2-3, p. 491.

    Mohr, Christine and Ettinger, Ulrich 2014. An Overview of the Association between Schizotypy and Dopamine. Frontiers in Psychiatry, Vol. 5,

    Reilly, J. L. Frankovich, K. Hill, S. Gershon, E. S. Keefe, R. S. E. Keshavan, M. S. Pearlson, G. D. Tamminga, C. A. and Sweeney, J. A. 2014. Elevated Antisaccade Error Rate as an Intermediate Phenotype for Psychosis Across Diagnostic Categories. Schizophrenia Bulletin, Vol. 40, Issue. 5, p. 1011.

    Reilly, J. L. and Sweeney, J. A. 2014. Generalized and Specific Neurocognitive Deficits in Psychotic Disorders: Utility for Evaluating Pharmacological Treatment Effects and as Intermediate Phenotypes for Gene Discovery. Schizophrenia Bulletin, Vol. 40, Issue. 3, p. 516.

    Bender, Julia Reuter, Benedikt Möllers, David Kaufmann, Christian Gallinat, Jürgen and Kathmann, Norbert 2013. Neural correlates of impaired volitional action control in schizophrenia patients. Psychophysiology, Vol. 50, Issue. 9, p. 872.

    Schmechtig, Anne Lees, Jane Grayson, Lois Craig, Kevin J. Dadhiwala, Rukiya Dawson, Gerard R. Deakin, J. F. William Dourish, Colin T. Koychev, Ivan McMullen, Katrina Migo, Ellen M. Perry, Charlotte Wilkinson, Lawrence Morris, Robin Williams, Steve C. R. and Ettinger, Ulrich 2013. Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. Psychopharmacology, Vol. 227, Issue. 2, p. 331.

    Schmechtig, A Lees, J Perkins, A Altavilla, A Craig, K J Dawson, G R William Deakin, J F Dourish, C T Evans, L H Koychev, I Weaver, K Smallman, R Walters, J Wilkinson, L S Morris, R Williams, S C R and Ettinger, U 2013. The effects of ketamine and risperidone on eye movement control in healthy volunteers. Translational Psychiatry, Vol. 3, Issue. 12, p. e334.

    Li, Qingyang Amlung, Michael T. Valtcheva, Manouela Camchong, Jazmin Austin, Benjamin P. Dyckman, Kara A. Unsworth, Nash Clementz, Brett A. and McDowell, Jennifer E. 2012. Evidence from cluster analysis for differentiation of antisaccade performance groups based on speed/accuracy trade-offs. International Journal of Psychophysiology, Vol. 85, Issue. 2, p. 274.

    Malsert, Jennifer Guyader, Nathalie Chauvin, Alan Polosan, Mircea Poulet, Emmanuel Szekely, David Bougerol, Thierry and Marendaz, Christian 2012. Antisaccades as a follow-up tool in major depressive disorder therapies: A pilot study. Psychiatry Research, Vol. 200, Issue. 2-3, p. 1051.

    Babin, Shelly L. Hood, Ashley J. Wassef, Adel A. Williams, Nina G. Patel, Saumil S. and Sereno, Anne B. 2011. Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: A saccadic eye movement study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, Issue. 7, p. 1753.

    Larrison, Abigail L. Babin, Shelly L. Xing, Yuan Patel, Saumil S. Wassef, Adel A. and Sereno, Anne B. 2011. Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia. Human Psychopharmacology: Clinical and Experimental, Vol. 26, Issue. 7, p. 517.

    Mazhari, Shahrzad Price, Greg Dragović, Milan Waters, Flavie A. Clissa, Peter and Jablensky, Assen 2011. Revisiting the suitability of antisaccade performance as an endophenotype in schizophrenia. Brain and Cognition, Vol. 77, Issue. 2, p. 223.

    Thakkar, Katharine N. Schall, Jeffrey D. Boucher, Leanne Logan, Gordon D. and Park, Sohee 2011. Response Inhibition and Response Monitoring in a Saccadic Countermanding Task in Schizophrenia. Biological Psychiatry, Vol. 69, Issue. 1, p. 55.

    Clementz, Brett A. Gao, Yuan McDowell, Jennifer E. Moratti, Stephan Keedy, Sarah K. and Sweeney, John A. 2010. Top-down control of visual sensory processing during an ocular motor response inhibition task. Psychophysiology, p. no.

    Hill, S Kristian Bishop, Jeffrey R Palumbo, Donna and Sweeney, John A. 2010. Effect of second-generation antipsychotics on cognition: current issues and future challenges. Expert Review of Neurotherapeutics, Vol. 10, Issue. 1, p. 43.

    Karatekin, C. Bingham, C. and White, T. 2010. Oculomotor and Pupillometric Indices of Pro- and Antisaccade Performance in Youth-Onset Psychosis and Attention Deficit/Hyperactivity Disorder. Schizophrenia Bulletin, Vol. 36, Issue. 6, p. 1167.

    Tu, P. Buckner, R. L. Zollei, L. Dyckman, K. A. Goff, D. C. and Manoach, D. S. 2010. Reduced functional connectivity in a right-hemisphere network for volitional ocular motor control in schizophrenia. Brain, Vol. 133, Issue. 2, p. 625.


Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia

  • DOI:
  • Published online: 03 January 2006

Background. Prefrontal cortical dysfunctions, including disturbances in adaptive context-specific behavior, have been reported in neuropsychological and brain imaging studies of schizophrenia. Some data suggest that treatment with antipsychotic medications may ameliorate these deficits.

Method. We investigated antisaccade performance in 39 antipsychotic-naive, first-episode schizophrenia patients who were re-evaluated 6 weeks after treatment initiation. A group of matched healthy subjects were examined at similar time-points. Patients and healthy individuals available for longer-term testing were re-assessed 26 and 52 weeks after initial testing.

Results. Before treatment, patients showed elevated rates of response suppression errors and prolonged latencies of correct antisaccades. Increased rates of antisaccade errors were associated with faster response latencies during a separate, visually guided saccade task, but only prior to treatment. Throughout the 1-year follow-up, patients progressively improved in their ability to voluntarily suppress context-inappropriate behavior. Although treatment assignment was by clinician choice, results of exploratory analyses revealed that patients treated with risperidone progressively planned and initiated correct antisaccades more quickly than patients receiving haloperidol.

Conclusions. Deficits in the voluntary control of spatial attention are exaggerated during acute episodes of illness, but remain an enduring aspect of prefrontal dysfunction in schizophrenia even after treatment. During acute illness, speeded sensorimotor transformations may compound these deficits and contribute to the heightened distractibility associated with acute psychosis. Continued improvement in task performance throughout the 1-year follow-up suggests that partial normalization of prefrontal cognitive functions resulting from antipsychotic treatment may have a longer and more gradual time course than the reduction of acute psychotic symptoms.

Corresponding author
Center for Cognitive Medicine, 912 S. Wood St, MC 913, University of Illinois at Chicago, Chicago, IL 60612, USA. (Email:
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *